Skip to content

The effect of prenatal supportive care of midwives in pregnant women with chronic diseases

The effect of prenatal supportive care of midwives in pregnant women with chronic diseases: Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220203053927N1
Enrollment
204
Registered
2022-02-10
Start date
2022-02-26
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prenatal supportive care. Maternal care for viable fetus in abdominal pregnancy

Interventions

Intervention 1: InterIntervention group: Supportive prenatal care in the intervention group consists of 3 components: (1) active and passive telephone counseling before and after delivery, (2) coordin

Sponsors

Shahroud University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Pregnant women with one or more chronic diseases that are diagnosed more than 6 months before pregnancy, with continued recurrence and need for medical treatment 2.Be between 16-20 weeks pregnant at the time of enrollment in the study 3.Single pregnancy 4.Be able to understand Persian speech and writing 5.To live in Ahvaz 6.Having a cell phone 7.Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: 1.Self-report history of substance abuse 2.Self-report of mental disorder and use of psychiatric drugs 3.Reluctance to continue participating in the study

Design outcomes

Primary

MeasureTime frame
The length of hospital stay (mean and standard deviation) is measured from the time of admission to the study until 2 weeks after delivery. Timepoint: Evaluation of this outcome will be done 2 weeks after delivery. Method of measurement: medical records.

Secondary

MeasureTime frame
World Health Organization 5-item Welfare Index. Timepoint: The evaluation will be performed at the beginning of the study (baseline), at 33-37 weeks of gestation and 6 weeks after delivery. Method of measurement: World Health Organization 5-item Welfare Scale World Health Organization 5-item Welfare Scale Questionnaire.;Pregnancy and postpartum depression. Timepoint: The evaluation will be performed at the beginning of the study (baseline), at 33-37 weeks of gestation and 6 weeks after delivery. Method of measurement: Edinburgh Postpartum Depression Scale.;Pregnancy worries. Timepoint: The evaluation will be done at the beginning of the study (baseline) and at 33-37 weeks of pregnancy. Method of measurement: Cambridge Pregnancy Anxiety Scale Questionnaire.;Health-related quality of life. Timepoint: The evaluation will be performed at the beginning of the study (baseline), at 33-37 weeks of gestation and 6 weeks after delivery. Method of measurement: Health-related quality of life questionnaire.;Quality prenatal care from the perspective of service recipients. Timepoint: Evaluation 6 weeks after delivery. Method of measurement: Quality of Prenatal Care Questionnaire.;Satisfaction with childbirth. Timepoint: Evaluation 2 weeks after delivery. Method of measurement: Maki Maternity Satisfaction Scale.;Economic consequences of health (use of health services). Timepoint: Evaluation 6 weeks after delivery. Method of measurement: Researcher-made questionnaire.;Prenatal health behaviors. Timepoint: The evaluation will be done at the beginning of the study (baseline) and at 33-37 weeks of pregnancy. Method of measurement: Prenatal health behaviors scale.;Consequences of pregnancy and childbirth. Timepoint: Evaluation 6 weeks after delivery. Method of measurement: Researcher-made questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Motaghi

Shahroud University of Medical Sciences

Zahra.motagy63@gmail.com+98 23 3239 5009

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026